Genetics of hypertension and cardiovascular disease and their interconnected pathways: Lessons from large studies

Current Hypertension Reports

Volumn 13, Issue 1, 2011, Pages 46-54

  Kraja, Aldi T ^a   Hunt, Steven C ^b   Rao, D C ^a   Dávila Román, Victor G ^a   Arnett, Donna K ^c   Province, Michael A ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Genome wide association studies; GWAS; Hypertension; Pathways; Single nucleotide polymorphisms; SNPs

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; BETA ADRENERGIC RECEPTOR; EPITHELIAL SODIUM CHANNEL; KALLIKREIN; PLASMINOGEN ACTIVATOR; RENIN; SODIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; VOLTAGE GATED CALCIUM CHANNEL;

AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAUCASIAN; GENE CONTROL; GENE REPLICATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC TRAIT; GENETIC VARIABILITY; HEART DISEASE; HEREDITY; HUMAN; HYPERTENSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; UNITED STATES;

EID: 79551574174     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0174-7     Document Type: Article

References (75)

1. BM Egan Y Zhao RN Axon 2010 US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2043 2050 1:CAS:528:DC%2BC3cXntVWrtLg%3D 10.1001/jama.2010.650 20501926
2. Q Gu R Paulose-Ram C Dillon V Burt 2006 Antihypertensive medication use among US adults with hypertension Circulation 113 213 221 1:CAS:528: DC%2BD28Xis1Kjsw%3D%3D 10.1161/CIRCULATIONAHA.105.542290 16391156
3. S MacMahon R Peto J Cutler, et al. 1990 Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 765 774 1:STN:280:DyaK3c3gsFegug%3D%3D 10.1016/0140-6736(90)90878-9 1969518 (Pubitemid 20106689)
4. RP Lifton AG Gharavi DS Geller 2001 Molecular mechanisms of human hypertension Cell 104 545 556 1:CAS:528:DC%2BD3MXis1Kks7w%3D 10.1016/S0092-8674(01)00241-0 11239411 (Pubitemid 32201949)
5. M Kanehisa S Goto M Furumichi M Tanabe M Hirakawa 2010 KEGG for representation and analysis of molecular networks involving diseases and drugs Nucleic Acids Res 38 Database issue D355 360 1:CAS:528:DC%2BC3cXktlygtg%3D%3D 10.1093/nar/gkp896 19880382 This article describes KEGG pathway databases
6. X Jeunemaitre F Soubrier YV Kotelevtsev, et al. 1992 Molecular basis of human hypertension: role of angiotensinogen Cell 71 169 180 1:CAS:528: DyaK38XmsV2gu7g%3D 10.1016/0092-8674(92)90275-H 1394429
7. WS Watkins SC Hunt GH Williams, et al. 2010 Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes J Hypertens 28 65 75 1:CAS:528:DC%2BD1MXhsFKgu73M 10.1097/HJH.0b013e328332031a 19770777
8. SC Hunt NR Cook A Oberman, et al. 1998 Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II Hypertension 32 393 401 1:CAS:528:DyaK1cXmtlyjsrk%3D 9740601
9. SE Easthope B Jarvis 2002 Candesartan cilexetil: an update of its use in essential hypertension Drugs 62 1253 1287 1:CAS:528:DC%2BD38XkvFSgtLw%3D 10.2165/00003495-200262080-00016 12010090
10. H Mukai WR Fitzgibbon G Bozeman, et al. 1996 Bradykinin B2 receptor antagonist increases chloride and water absorption in rat medullary collecting duct Am J Physiol 271 R352 360 1:CAS:528:DyaK28XlsFarsb8%3D 8770134
11. AT Kraja MA Province D Arnett, et al. 2007 Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond) 4 1 28 10.1186/1743-7075-4-28 (Pubitemid 351327208)
12. NC Adragna PK Lauf 2007 K-Cl cotransport function and its potential contribution to cardiovascular disease Pathophysiology 14 135 146 1:CAS:528:DC%2BD2sXhsVSnsrnN 10.1016/j.pathophys.2007.09.007 17949953 (Pubitemid 350166888)
13. W Ji JN Foo BJ O'Roak, et al. 2008 Rare independent mutations in renal salt handling genes contribute to blood pressure variation Nat Genet 40 592 599 1:CAS:528:DC%2BD1cXltFylurg%3D 10.1038/ng.118 18391953 This article emphasizes the importance of rare variants in BP variation (Pubitemid 351601207)
14. L Schild Y Lu I Gautschi, et al. 1996 Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome EMBO J 15 2381 2387 1:CAS:528:DyaK28XjsVGjur4%3D 8665845
15. DM Dunn T Ishigami J Pankow, et al. 2002 Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript J Hum Genet 47 665 676 1:CAS:528:DC%2BD3sXhs1Ojsg%3D%3D 10.1007/s100380200102 12522688 (Pubitemid 36083250)
16. L Schild 2010 The epithelial sodium channel and the control of sodium balance Biochim Biophys Acta 1802 1159 65 1:CAS:528:DC%2BC3cXhtlKkt7zL 20600867 This is a good review on sodium channels
17. FH Wilson S Disse-Nicodème KA Choate, et al. 2001 Human hypertension caused by mutations in WNK kinases Science 293 1107 1112 1:CAS:528:DC%2BD3MXmtVWrsrw%3D 10.1126/science.1062844 11498583 (Pubitemid 32758085)
18. S Uchida 2010 Pathophysiological roles of WNK kinases in the kidney Pflugers Arch. 460 695 702 1:CAS:528:DC%2BC3cXhtVSmt7jO 10.1007/s00424-010-0848- 7 20490538
19. PA Welling YP Chang E Delpire JB Wade 2010 Multigene kinase network, kidney transport, and salt in essential hypertension Kidney Int 77 1063 1069 1:CAS:528:DC%2BC3cXmsF2is7w%3D 10.1038/ki.2010.103 20375989
20. M Chiga T Rai SS Yang, et al. 2008 Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone Kidney Int 74 1403 1409 1:CAS:528:DC%2BD1cXhtlOjtrrP 10.1038/ki.2008.451 18800028
21. L Citterio C Lanzani P Manunta G Bianchi 2010 Genetics of primary hypertension: The clinical impact of adducin polymorphisms Biochim Biophys Acta 1802 1285 98 1:CAS:528:DC%2BC3cXhtlKkt7rO 20382219 This article reviews the adducin role by expanding into the idea of system networks
22. D Levy GB Ehret K Rice, et al. 2009 Genome-wide association study of blood pressure and hypertension Nat Genet 41 677 687 1:CAS:528: DC%2BD1MXls1Cmurk%3D 10.1038/ng.384 19430479 This is one of the largest GWAS for BP and HT
23. DK Arnett SA Claas 2009 Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance Pharmacogenomics 10 1295 1307 1:CAS:528:DC%2BD1MXpslOmurk%3D 10.2217/pgs.09.61 19663674 This is a review of the lag of personalized antihypertensive treatment
24. BA Vakili PM Okin RB Devereux 2001 Prognostic implications of left ventricular hypertrophy Am Heart J 141 334 341 1:STN:280:DC%2BD3M3hs1KlsQ%3D%3D 10.1067/mhj.2001.113218 11231428 (Pubitemid 32200259)
25. P Osei-Owusu X Sun RM Drenan, et al. 2007 Regulation of RGS2 and second messenger signaling in vascular smooth muscle cells by cGMP-dependent protein kinase J Biol Chem 282 31656 31665 1:CAS:528:DC%2BD2sXhtFykurfK 10.1074/jbc.M706360200 17681944 (Pubitemid 350044901)
26. AN Simão MA Lozovoy TN Simão, et al. 2010 Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil Arq Bras Endocrinol Metabol 54 540 545 20857058
27. H Wang T Shimosawa H Matsui, et al. 2008 Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions J Hypertens 26 1453 1462 1:CAS:528: DC%2BD1cXntFWgtL4%3D 10.1097/HJH.0b013e328300a232 18551023
28. S Masuki M Mori Y Tabara, et al. 2010 Shinshu University Genetic Research Consortium. Vasopressin V1a receptor polymorphism and interval walking training effects in middle-aged and older people Hypertension 55 747 754 1:CAS:528:DC%2BC3cXitVKrsbo%3D 10.1161/HYPERTENSIONAHA.109.147728 20142561
29. SB Chai XM Li YZ Pang, et al. 2010 Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease Heart Vessels 25 138 143 10.1007/s00380-009-1178-6 20339975
30. RR Williams DC Rao RC Ellison, et al. 2000 NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network Ann Epidemiol 10 389 400 1:STN:280: DC%2BD3cvntVWqtw%3D%3D 10.1016/S1047-2797(00)00063-6 10964005 (Pubitemid 30645793)
31. AT Kraja SC Hunt JS Pankow, et al. 2005 An evaluation of the metabolic syndrome in the HyperGEN study Nutr Metab (Lond) 2 1 2 10.1186/1743-7075-2-2 (Pubitemid 40393490)
32. AL Price NJ Patterson RM Plenge, et al. 2006 Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 904 909 1:CAS:528:DC%2BD28XnsVCgsrg%3D 10.1038/ng1847 16862161 (Pubitemid 44141658)
33. YF Li C LaCroix J Freeling 2009 Specific subtypes of nicotinic cholinergic receptors involved in sympathetic and parasympathetic cardiovascular responses Neurosci Lett 462 20 23 1:CAS:528:DC%2BD1MXoslegsrk%3D 10.1016/j.neulet.2009.06.081 19573576
34. B Fine C Hodakoski S Koujak, et al. 2009 Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a Science 325 1261 1265 1:CAS:528:DC%2BD1MXhtVOmsrnO 10.1126/science.1173569 19729658
35. K Kohara Y Tabara J Nakura, et al. 2008 Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension Hypertens Res 31 203 212 1:CAS:528:DC%2BD1cXmt1artr8%3D 10.1291/hypres.31.203 18360038 This article discusses an important initiative for detecting HT genes in Japan (Pubitemid 351461098)
36. T Brenner KM O'Shaughnessy 2008 Both TASK-3 and TREK-1 two-pore loop K channels are expressed in H295R cells and modulate their membrane potential and aldosterone secretion Am J Physiol Endocrinol Metab 295 E1480 1486 1:CAS:528:DC%2BD1cXhsFWgtb%2FL 10.1152/ajpendo.90652.2008 18854423
37. RS Vasan MG Larson J Aragam, et al. 2007 Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study BMC Med Genet 8 Suppl 1 S2 10.1186/1471-2350-8-S1-S2 17903301 (Pubitemid 351958757)
38. LA Barbour S Mizanoor Rahman, et al. 2005 Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess J Biol Chem 280 37489 37494 1:CAS:528:DC%2BD2MXhtF2isrvF 10.1074/jbc.M506967200 16166093 (Pubitemid 41642357)
39. NL Thomas C Maxwell S Mukherjee AJ Williams 2010 Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction FEBS Lett 584 2153 2160 1:CAS:528:DC%2BC3cXlvVaqs74%3D 10.1016/j.febslet.2010.01.057 20132818
40. Wellcome Trust Case Control Consortium 2007 Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls Nature 447 661 678 10.1038/nature05911 (Pubitemid 46889737)
41. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research R Saxena BF Voight V Lyssenko, et al. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 1:CAS:528: DC%2BD2sXmtVyitrk%3D 10.1126/science.1142358 17463246 (Pubitemid 46871653)
42. C Sabatti SK Service AL Hartikainen, et al. 2009 Genome-wide association analysis of metabolic traits in a birth cohort from a founder population Nat Genet 41 35 46 1:CAS:528:DC%2BD1cXhsVKlt7zO 10.1038/ng.271 19060910
43. C Newton-Cheh T Johnson V Gateva, et al. 2009 Genome-wide association study identifies eight loci associated with blood pressure Nat Genet 41 666 676 1:CAS:528:DC%2BD1MXls1CmsbY%3D 10.1038/ng.361 19430483 This is one of the largest GWAS for BP
44. Chung CM, Wang RY, Chen JW, et al. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J. 2010, 1-8.
45. AD Johnson Y Gong D Wang, et al. 2009 Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension Clin Pharmacol Ther 85 36 44 1:CAS:528:DC%2BD1cXhsFSmtrfO 10.1038/clpt.2008.194 18946466
46. F Thameem VS Voruganti X He, et al. 2008 Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans Hum Genet 124 557 559 1:CAS:528: DC%2BD1cXhsVCku77K 10.1007/s00439-008-0581-x 18985387
47. JG Smith JK Lowe S Kovvali, et al. 2009 Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae Heart Rhythm 6 634 641 10.1016/j.hrthm.2009.02.022 19389651
48. M Martinez-Moreno A Alvarez-Barrientos F Roncal, et al. 2005 Direct interaction between the reductase domain of endothelial nitric oxide synthase and the ryanodine receptor FEBS Letters 579 3159 3163 1:CAS:528: DC%2BD2MXltVKgtLo%3D 10.1016/j.febslet.2005.04.078 15922337 (Pubitemid 40797852)
49. S Kim HM Yun JH Baik, et al. 2007 Functional interaction of neuronal Cav1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus J Biol Chem 282 32877 32889 1:CAS:528:DC%2BD2sXht1CltbfJ 10.1074/jbc.M701418200 17823125 (Pubitemid 350159320)
50. LG Mikael J Genest Jr R Rozen 2006 Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease Circ Res 98 564 571 1:CAS:528:DC%2BD28Xhs1Gqs7o%3D 10.1161/01.RES.0000204825.66410.0b 16439690
51. V Pizza A Bisogno E Lamaida, et al. 2010 Migraine and coronary artery disease: an open study on the genetic polymorphism of the 5, 10 methylenetetrahydrofolate (MTHFR) and angiotensin I-converting enzyme (ACE) genes Cent Nerv Syst Agents Med Chem 10 91 96 1:CAS:528:DC%2BC3cXns1SltL8%3D 20518725
52. JD Roberts RW Davies SA Lubitz, et al. 2010 Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation Europace 12 1078 1083 10.1093/europace/euq161 20543198
53. EJ Benjamin KM Rice DE Arking, et al. 2009 Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry Nat Genet 41 879 881 1:CAS:528:DC%2BD1MXosFWhsbo%3D 10.1038/ng.416 19597492
54. C Newton-Cheh M Eijgelsheim KM Rice, et al. 2009 Common variants at ten loci influence QT interval duration in the QTGEN Study Nat Genet 41 399 406 1:CAS:528:DC%2BD1MXjsVCqtLc%3D 10.1038/ng.364 19305408 This is one of the largest studies for cardiac traits
55. A Pfeufer S Sanna DE Arking, et al. 2009 Common variants at ten loci modulate the QT interval duration in the QTSCD Study Nat Genet 41 407 414 1:CAS:528:DC%2BD1MXjsVCqurk%3D 10.1038/ng.362 19305409 This is one of the largest studies for cardiac traits
56. A Adeyemo N Gerry G Chen, et al. 2009 A genome-wide association study of hypertension and blood pressure in African Americans PLoS Genet 5 7 e1000564 10.1371/journal.pgen.1000564 19609347
57. C Vangjeli N Clarke U Quinn, et al. 2010 Confirmation that the renin gene distal enhancer polymorphism REN-5312C/T is associated with increased blood pressure Circ Cardiovasc Genet 3 53 59 1:CAS:528:DC%2BC3cXjslSgsbg%3D 10.1161/CIRCGENETICS.109.899930 20160196
58. M Eijgelsheim C Newton-Cheh N Sotoodehnia, et al. 2010 Genome-wide association analysis identifies multiple loci related to resting heart rate Hum Mol Genet 19 3885 3894 1:CAS:528:DC%2BC3cXhtFCrsr3L 10.1093/hmg/ddq303 20639392
59. F Marroni A Pfeufer YS Aulchenko, et al. 2009 EUROSPAN Consortium. A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project Circ Cardiovasc Genet 2 322 328 1:CAS:528:DC%2BD1MXhtFCgtr7O 10.1161/CIRCGENETICS.108.833806 20031603
60. YS Cho MJ Go YJ Kim, et al. 2009 A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits Nat Genet 41 527 534 1:CAS:528:DC%2BD1MXltValt7k%3D 10.1038/ng.357 19396169 This article reports a large initiative in South Korea for studying BP/HT genes, among others
61. JC Chambers J Zhao CM Terracciano, et al. 2010 Genetic variation in SCN10A influences cardiac conduction Nat Genet 42 149 152 1:CAS:528: DC%2BC3cXjsVegtg%3D%3D 10.1038/ng.516 20062061
62. H Holm DF Gudbjartsson DO Arnar, et al. 2010 Several common variants modulate heart rate, PR interval and QRS duration Nat Genet 42 117 122 1:CAS:528:DC%2BC3cXjsVemtQ%3D%3D 10.1038/ng.511 20062063
63. A Pfeufer C van Noord KD Marciante, et al. 2010 Genome-wide association study of PR interval Nat Genet 42 153 159 1:CAS:528:DC%2BC3cXjsVehsA%3D%3D 10.1038/ng.517 20062060
64. AC Morrison JF Felix LA Cupples, et al. 2010 Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium Circ Cardiovasc Genet 3 248 255 1:CAS:528:DC%2BC3cXpt1aqs74%3D 10.1161/CIRCGENETICS.109.895995 20400778
65. JK Lowe JB Maller I Pe'er, et al. 2009 Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae PLoS Genet 5 2 e1000365 10.1371/journal.pgen.1000365 19197348 This article discusses BP/HT gene discovery in an isolated population
66. RS Vasan NL Glazer JF Felix, et al. 2009 Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data JAMA 302 168 178 1:CAS:528:DC%2BD1MXosVSku7o%3D 10.1001/jama.2009.978-a 19584346
67. AT Kraja DC Rao AB Weder, et al. 2005 Two major QTLs and several others relate to factors of metabolic syndrome in the Family Blood Pressure Program Hypertension 46 751 757 1:CAS:528:DC%2BD2MXhtV2htr%2FE 10.1161/01.HYP. 0000184249.20016.bb 16172425 (Pubitemid 43186749)
68. AT Kraja SC Hunt JS Pankow, et al. 2005 Quantitative trait loci for metabolic syndrome in the Hypertension Genetic Epidemiology Network study Obes Res 13 1885 1890 10.1038/oby.2005.231 16339118
69. AT Kraja P Huang W Tang, et al. 2008 QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the Hypertension Genetic Epidemiology Network study BMC Med Genet 9 103 10.1186/1471-2350-9-103 19038053
70. E Org S Eyheramendy P Juhanson, et al. 2009 Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations Hum Mol Genet 18 2288 2296 1:CAS:528:DC%2BD1MXmtlWnt7s%3D 10.1093/hmg/ddp135 19304780
71. AA Khan EC Chow RJ Porte, et al. 2009 Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver Biopharm Drug Dispos 30 241 258 1:CAS:528:DC%2BD1MXnvFKhu7o%3D 10.1002/bdd.663 19562681
72. HC Yang YJ Liang YL Wu, et al. 2009 Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan PLoS One 4 5 e5459 10.1371/journal.pone.0005459 19421330
73. Y Wang JR O'Connell PF McArdle, et al. 2009 From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene Proc Natl Acad Sci U S A 106 226 231 1:CAS:528:DC%2BD1MXltF2ksQ%3D%3D 10.1073/pnas.0808358106 19114657
74. ST Turner KR Bailey BL Fridley, et al. 2008 Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic Hypertension 52 359 365 1:CAS:528:DC%2BD1cXosF2js74%3D 10.1161/HYPERTENSIONAHA.107.104273 18591461
75. D Levy MG Larson EJ Benjamin, et al. 2007 Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness BMC Med Genet 8 Suppl 1 S3 10.1186/1471-2350-8-S1-S3 17903302 (Pubitemid 351958756)